Design of lipid nanoparticle delivery agents for multivalent display of recombinant Env trimers in HIV vaccination

by Pejawar Gaddy, Sharmila, Kovacs, J., Barouch, D., Chen, B., Irvine, Darrell J.
Published 2013

Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice

by Barouch, D.H, Barrett, J., Bondzie, E.A, Gebre, M.S, Jacob-Dolan, C., Mahrokhian, S.H, McMahan, K., Powers, O., Schuitemaker, H., Tostanoski, L.H, Wan, H., Wegmann, F., Ye, T., Yu, J., Zahn, R.C
Published 2022

Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates

by Alter, G., Andersen, H., Barouch, D.H, Borducchi, E.N, Brown, R., Cook, A., Finneyfrock, B., Gorman, M.J, Lauffenburger, D.A, Lewis, M.G, Lifton, M., Liu, J., McMahan, K., Mercado, N.B, Nampanya, F., Patel, S., Pessaint, L., Peter, L., Teow, E., Tostanoski, L.H, Van Ry, A., Velasco, J., Yu, J., Yuan, D., Zhu, D.Y
Published 2022

A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques

by Andersen, H., Barouch, D.H, Carnahan, R.H, Chandrashekar, A., Chen, R.E, Cobb, R.R, Collins, L., Cook, A., Crowe, J.E., Jr, Diamond, M.S, Dorsey, N.M, Earnhart, C.G, Gilchuk, P., Hackett, K., Hechenblaickner, M., Hopkins, S.A, Hoppe, B., House, R.V, Lewis, M.G, Nkolola, J., Nonet, G.H, Slaughter, J.C, Snow, D.M, Tomic, M.T, VanBlargan, L.A, Yu, J.
Published 2022

Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters

by Andersen, H., Ansel, J.L, Barouch, D.H, Barrett, J., Bradette, H., Cayer, K., Chandrashekar, A., Chang, A., Cox, F., de Groot, A.M, Gardner, S., Heerwegh, D., Holman, S., Jacob-Dolan, C., Jaegle, K., Kar, S., Le Gars, M., Lewis, M.G, Lok, M., Nase, D., Patel, S., Porto, M., Powers, O.C, Sadoff, J., Sanborn, O., Schuitemaker, H., Seaman, M.S, Sellers, D., Spence, B., Stephenson, K.E, Tolboom, J.T.B.M, Tostanoski, L.H, Wegmann, F., Yu, J., Zahn, R.C
Published 2022

Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Cli...

by Bar, K.J, Barnabas, R.V, Barouch, D.H, Baum, A., Braunstein, N., Brown, E.R, Burwen, D.R, Chan, K.-C, Cohen, M.S, Davis, J.D, Dicioccio, A.T, Forleo-Neto, E., Geba, G.P, Hamilton, J.D, Heirman, I., Herman, G., Hooper, A.T, Hou, P., Hurt, C.B, Isa, F., Kim, Y., Kowal, B., Krainson, J., Kyratsous, C.A, Lipsich, L., Mahmood, A., Marovich, M.A, Mohseni, R., Musser, B.J, O'Brien, M.P, Perez-Perez, R., Purcell, L.A, Ramesh, D., Sarkar, N., Stahl, N., Turner, K.C, Weinreich, D.M, Yancopoulos, G.D
Published 2022

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study

by Ahmed, K., Badal-Faesen, S., Barnabas, S., Barouch, D., Bekker, L.-G, Bennett, S., Boulle, A., Bradshaw, D., Brumskine, W., Burgess, L., Champion, J., Chen, T., Cohen, C., Collie, S., Corey, L., Davies, M.-A, Dawson, R., de Oliveira, T., Diacon, A., Dubula, T., Engelbrecht, I., Fairall, L., Garrett, N., Gill, K., Goga, A., Gray, G.E, Grobbelaar, C., Groome, M., Innes, J.C, Jacobson, B., Jassat, W., Kassanjee, R., Kassim, S., Khuto, K., Kotze, P., Kotze, S., Lazarus, E., Le Roux, E., Lessells, R.J, Lombaard, J., Louw, V., Luabeya, A., Maboa, R.M, Mahomed, H., Mahoney, S.H, Makhaza, D., Malan, D.R, Mamba, M.B, Mametja, S., Mayat, F., Mda, P., Meintjes, G., Mngadi, K., Mohlala, P., Moultrie, H., Mulder, M., Naicker, N., Naicker, V., Naidoo, L., Nana, A., Nchabeleng, M., Odhiambo, J., Opie, J., Patel, F., Peter, J.G, Petrick, F.G, Reddy, T., Rousseau, P., Rowji, P., Sanne, I., Semenya, M., Seocharan, I., Sisonke Protocol Team, Sisonke Study Team, Spooner, E., Takalani, A., Takuva, S., Urbach, D., van Nieuwenhuizen, E., Von Gottberg, A., Ward, A., Wolmarans, M., Yende-Zuma, N.
Published 2022